000			04006nam a22004455i 4500
001			978-0-387-23600-1
003			DE-He213
005			20250710083929.0
007			cr nn 008mamaa
008			100509s2005 xxu| s |||| 0|eng d
020			_a9780387236001 _a99780387236001
024	7		_a10.1007/978-0-387-23600-1 _2doi
082	0	4	_a616.15 _223
100	1		_aSmit Sibinga, C. TH. _eeditor.
245	1	0	_aNeonatology and Blood Transfusion _h[recurso electrónico] : _bProceedings of the Twenty-Eighth International Symposium on Blood Transfusion, Groningen, NL Organized by the Sanquin Division Blood Bank Noord Nederland / _cedited by C. TH. Smit Sibinga, N. Luban.
264		1	_aBoston, MA : _bSpringer US, _c2005.
300			_aXV, 294 p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_arecurso en línea _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aDevelopments in Hematology and Immunology ; _v39
505	0		_aFoetal and Neonatal Haematology -- Regulation of Developmental Haematopoiesis By Gata Transcription Factors -- Development of The Immune System In The Foetal and Perinatal Period -- Foetal and Neonatal Immunohaematological Responses: Consequences for Practical Management? -- Biology of Thrombopoietin In the Human Foetus and Neonate -- Discussion -- Immunohaematology and Haemostasis -- Management of Red Cell Alloimmunization in Pregnancy -- New Treatment Options in Neonatal Hyperbilirubinaemia -- Consensus and Controversy in Foetal and Neonatal Alloimmune Thrombocytopenia -- The Bleeding Infant -- Discussion -- Blood Transfusion in the Neonate -- Neonatal Thrombosis -- Criteria for Selecting a Red Blood Cell Product to Transfuse Anaemic Infants -- Hazards of Transfusion: GvHD -- Non-Immune, Non-Infectious Complications of Transfusion -- Extracorporeal Membrane Oxygenation in the Neonate with Respiratory Failure -- Discussion -- Cellular Therapies in Neonatology -- Genetic Engineering for the Foetus and Neonate -- Meta-Analysis and Evidence-Based Decision Making in Neonatal Care -- Placental Blood Banking in the Year 2003 -- Discussion -- Epilogue -- Epilogue.
520			_aNeonatology and Blood Transfusion Proceedings of the Twenty-Eighth International Symposium on Blood Transfusion, Groningen, NL, Organized by the Sanquin Division Blood Bank North-East, Groningen It is in many ways fitting that the last of these international symposia on blood transfusion should end with neonatal blood transfusion. The most fragile, least well studied and most at risk population requires special care and concern. We need to expand our knowledge of their unique physiology, biochemical pathways and in planning treatment and interventions, always "do no harm." This proceedings of the last Groningen symposium presents a wealth of information on developmental immunology, the molecular basis of haematopoeisis, physiological basis of bleeding and thrombosis, transfusion risks and benefits and lastly, future therapies. Infants provide us with much to learn but in turn they will be the providers of (through cord blood) and the recipients of (through cellular engineering) the best that science can offer. Translational research, which has been the thrust of these presentations for 28 years, will benefit them in a way that no scientist could have ever predicted.
650		0	_aMEDICINE.
650		0	_aBLOOD TRANSFUSION.
650		0	_aHEMATOLOGY.
650	1	4	_aMEDICINE & PUBLIC HEALTH.
650	2	4	_aHEMATOLOGY.
650	2	4	_aBLOOD TRANSFUSION MEDICINE.
700	1		_aLuban, N. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9780387235998
830		0	_aDevelopments in Hematology and Immunology ; _v39
856	4	0	_uhttp://dx.doi.org/10.1007/978-0-387-23600-1 _zVer el texto completo en las instalaciones del CICY
912			_aZDB-2-SME
942			_2ddc _cER
999			_c56233 _d56233